Cardio-Oncology Referral for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 Oct 2025: Trial registered, NCT07223385
  2. 15 Jul 2026: Trial started, NCT07223385

The trials

NCT07223385: High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

State
Under way
Phase
Phase 2
People
80 planned
Started
15 Jul 2026
Primary completion
Aug 2030
Arms
Cardo-Oncolody Referral
Results
None posted
  1. 31 Oct 2025: Trial registered
  2. 15 Jul 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.